■本研究旨在确定自体PRP在肛瘘中的疗效和安全性。
■搜索是在电子数据库中进行的,例如;PubMed,Scopus,谷歌学者,Embase,科克伦图书馆本研究调查的结果是改善率,复发率,和大便失禁的发生率。
■治疗,失禁,复发率为68%(95%CI,.60-.76),27%(95%CI,.12-.46),和18%(95%CI,.12-.26),分别。与对照组相比,PRP治疗组患者的合并改善率为1.35倍,差异有统计学意义(合并OR=1.35,95%CI,1.14-1.60,P<001)。与对照组相比,PRP治疗组的合并复发率为1.17,无统计学意义(合并OR=1.17,95%CI,0.44-3.11)。
■富含血小板的血浆是治愈肛瘘患者的有效方法。
UNASSIGNED: This study aimed to determine the efficacy and safety of autologous PRP in anal fistula.
UNASSIGNED: The search was done in electronic databases such as; PubMed, Scopus, Google Scholar, Embase, and Cochrane Library. The outcomes investigated in this study were the rate of improvement, the rate of recurrence, and the rate of fecal incontinence.
UNASSIGNED: Cure, incontinence, and recurrence rates were 68% (95% CI, .60-.76), 27% (95% CI, .12-.46), and 18% (95% CI, .12-.26), respectively. The pooled improvement ratio in patients treated with PRP compared to control group was 1.35 times, which was statistically significant (pooled OR=1.35, 95% CI, 1.14-1.60, P<001). The pooled recurrence ratio in patients treated with PRP compared to control group was 1.17, which was not statistically significant (pooled OR=1.17, 95% CI, 0.44-3.11).
UNASSIGNED: Platelet-rich plasma is an effective method of healing people with anal fistula.